Xcelience, a contract development and manufacturing organization (CDMO), is expanding product development services and manufacturing operations in its home base of Tampa, FL. The project will create 100 new jobs while retaining another 100 jobs. In addition, Xcelience will also invest $9 million in the region as part of the expansion.

The CDMO announced plans to increase capacity in their manufacturing facilities with a 6,000 square foot expansion at their 5415 W. Laurel Street location. In addition, Xcelience will expand its pharmaceutical development labs in a new 71,000 square foot headquarters at 4910 Savarese Circle in Tampa to support future company growth. The positions will include staff for pharmaceutical development, manufacturing, quality assurance and packaging.

“Tampa is a great place to build a base of scientific capabilities,” said Derek Hennecke, president and chief executive officer of Xcelience. “The warm climate attracts a stable workforce, and the government at all levels is eager to help us grow and prosper. Our location puts us just a mile from the airport, making it easy for out of state clients to find us. Exciting things are coming
down the pipeline for Tampa, for Xcelience, and the exciting new medical treatments we are developing with our clients.”

Xcelience provides preformulation, formulation development, analytical services, GMP manufacturing, small-scale commercial manufacturing, and global clinical supplies packaging and logistics to help companies move a drug into clinical trials.